Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-23-011782

Chief Executive Officer gave up 6,373 shares (to pay taxes)

  • Chief Executive Officer acquired 13,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2023-02-18 Option exercise +13,250 382,361 D
Kulkarni Samarth Chief Executive Officer 2023-02-21 Shares withheld for taxes −6,373 $48.26 $307,561 375,988 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2023-02-18 Option exercise · Restricted Stock Units −13,250 39,750 D
Loading xslF345X03/doc4.xml…